420 related articles for article (PubMed ID: 30559138)
1. Evaluation of 4-Amino 2-Anilinoquinazolines against
Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
[TBL] [Abstract][Full Text] [Related]
2. Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity.
Ashton TD; Ngo A; Favuzza P; Bullen HE; Gancheva MR; Romeo O; Parkyn Schneider M; Nguyen N; Steel RWJ; Duffy S; Lowes KN; Sabroux HJ; Avery VM; Boddey JA; Wilson DW; Cowman AF; Gilson PR; Sleebs BE
Bioorg Chem; 2021 Dec; 117():105359. PubMed ID: 34689083
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
4. Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity.
Gilson PR; Tan C; Jarman KE; Lowes KN; Curtis JM; Nguyen W; Di Rago AE; Bullen HE; Prinz B; Duffy S; Baell JB; Hutton CA; Jousset Subroux H; Crabb BS; Avery VM; Cowman AF; Sleebs BE
J Med Chem; 2017 Feb; 60(3):1171-1188. PubMed ID: 28080063
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.
Szajnman SH; Galaka T; Li ZH; Li C; Howell NM; Chao MN; Striepen B; Muralidharan V; Moreno SN; Rodriguez JB
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895021
[TBL] [Abstract][Full Text] [Related]
6. Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.
Ganfon H; Bero J; Tchinda AT; Gbaguidi F; Gbenou J; Moudachirou M; Frédérich M; Quetin-Leclercq J
J Ethnopharmacol; 2012 May; 141(1):411-7. PubMed ID: 22440261
[TBL] [Abstract][Full Text] [Related]
7. Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum.
Penna-Coutinho J; Aguiar AC; Krettli/ AU
Mem Inst Oswaldo Cruz; 2018 Dec; 113(12):e180279. PubMed ID: 30540020
[TBL] [Abstract][Full Text] [Related]
8. Antiplasmodial efficacy of
Satish PVV; Kumari DS; Sunita K
J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
[TBL] [Abstract][Full Text] [Related]
9. 4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum.
Verhaeghe P; Dumètre A; Castera-Ducros C; Hutter S; Laget M; Fersing C; Prieri M; Yzombard J; Sifredi F; Rault S; Rathelot P; Vanelle P; Azas N
Bioorg Med Chem Lett; 2011 Oct; 21(19):6003-6. PubMed ID: 21852132
[TBL] [Abstract][Full Text] [Related]
10. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
[TBL] [Abstract][Full Text] [Related]
11. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
[TBL] [Abstract][Full Text] [Related]
12. Search for new pharmacophores for antimalarial activity. Part III: synthesis and bioevaluation of new 6-thioureido-4-anilinoquinazolines.
Mishra A; Srivastava K; Tripathi R; Puri SK; Batra S
Eur J Med Chem; 2009 Nov; 44(11):4404-12. PubMed ID: 19586687
[TBL] [Abstract][Full Text] [Related]
13. Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.
Dzierszinski F; Coppin A; Mortuaire M; Dewailly E; Slomianny C; Ameisen JC; DeBels F; Tomavo S
Antimicrob Agents Chemother; 2002 Oct; 46(10):3197-207. PubMed ID: 12234845
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial and antiplasmodial activity of husk extract and fractions of Zea mays.
Okokon JE; Antia BS; Mohanakrishnan D; Sahal D
Pharm Biol; 2017 Dec; 55(1):1394-1400. PubMed ID: 28320254
[TBL] [Abstract][Full Text] [Related]
15. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
[TBL] [Abstract][Full Text] [Related]
16. A conserved coccidian gene is involved in Toxoplasma sensitivity to the anti-apicomplexan compound, tartrolon E.
Bowden GD; Reis PM; Rogers MB; Bone Relat RM; Brayton KA; Wilson SK; Di Genova BM; Knoll LJ; Nepveux V FJ; Tai AK; Ramadhar TR; Clardy J; O'Connor RM
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():1-7. PubMed ID: 32738587
[TBL] [Abstract][Full Text] [Related]
17. Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
Baumeister S; Wiesner J; Reichenberg A; Hintz M; Bietz S; Harb OS; Roos DS; Kordes M; Friesen J; Matuschewski K; Lingelbach K; Jomaa H; Seeber F
PLoS One; 2011 May; 6(5):e19334. PubMed ID: 21573242
[TBL] [Abstract][Full Text] [Related]
18. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
Vijayaraghavan S; Mahajan S
Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro.
Radke JB; Burrows JN; Goldberg DE; Sibley LD
ACS Infect Dis; 2018 Aug; 4(8):1264-1274. PubMed ID: 29998728
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.
Malmquist NA; Moss TA; Mecheri S; Scherf A; Fuchter MJ
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16708-13. PubMed ID: 23011794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
